108 related articles for article (PubMed ID: 17182888)
21. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.
Antonelli T; Tomasini MC; Mazza R; Fuxe K; Gaetani S; Cuomo V; Tanganelli S; Ferraro L
J Pharmacol Exp Ther; 2009 May; 329(2):708-17. PubMed ID: 19197005
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.
Eggan SM; Lewis DA
Cereb Cortex; 2007 Jan; 17(1):175-91. PubMed ID: 16467563
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
25. Constitutive endocytosis and recycling of the neuronal glutamate transporter, excitatory amino acid carrier 1.
González MI; Susarla BT; Fournier KM; Sheldon AL; Robinson MB
J Neurochem; 2007 Dec; 103(5):1917-31. PubMed ID: 17868307
[TBL] [Abstract][Full Text] [Related]
26. Identification of a presynaptic cannabinoid CB1 receptor in the guinea-pig atrium and sequencing of the guinea-pig CB1 receptor.
Kurz CM; Gottschalk C; Schlicker E; Kathmann M
J Physiol Pharmacol; 2008 Mar; 59(1):3-15. PubMed ID: 18441383
[TBL] [Abstract][Full Text] [Related]
27. Novel sterically hindered cannabinoid CB1 receptor ligands.
Urbani P; Cascio MG; Ramunno A; Bisogno T; Saturnino C; Di Marzo V
Bioorg Med Chem; 2008 Aug; 16(15):7510-5. PubMed ID: 18579386
[TBL] [Abstract][Full Text] [Related]
28. Receptor-type PTP-NP inhibition of Dynamin-1 GTPase activity is associated with neuronal depolarization.
Jiang S; Avraham HK; Kim TA; Rogers RA; Avraham S
Cell Signal; 2006 Sep; 18(9):1439-46. PubMed ID: 16413169
[TBL] [Abstract][Full Text] [Related]
29. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
Merighi S; Simioni C; Gessi S; Varani K; Borea PA
Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
[TBL] [Abstract][Full Text] [Related]
30. Type I cannabinoid receptor trafficking: all roads lead to lysosome.
Rozenfeld R
Traffic; 2011 Jan; 12(1):12-8. PubMed ID: 21040297
[TBL] [Abstract][Full Text] [Related]
31. Axon-dominant localization of cell-surface cholesterol in cultured hippocampal neurons and its disappearance in Niemann-Pick type C model cells.
Tashiro Y; Yamazaki T; Shimada Y; Ohno-Iwashita Y; Okamoto K
Eur J Neurosci; 2004 Oct; 20(8):2015-21. PubMed ID: 15450080
[TBL] [Abstract][Full Text] [Related]
32. Endocytotic elimination and domain-selective tethering constitute a potential mechanism of protein segregation at the axonal initial segment.
Fache MP; Moussif A; Fernandes F; Giraud P; Garrido JJ; Dargent B
J Cell Biol; 2004 Aug; 166(4):571-8. PubMed ID: 15302857
[TBL] [Abstract][Full Text] [Related]
33. Co-distribution of the cannabinoid CB1 receptor and the 5-HT transporter in the rat amygdale.
Ashton JC; Darlington CL; Smith PF
Eur J Pharmacol; 2006 May; 537(1-3):70-1. PubMed ID: 16624281
[TBL] [Abstract][Full Text] [Related]
34. The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis.
de Hoop MJ; Huber LA; Stenmark H; Williamson E; Zerial M; Parton RG; Dotti CG
Neuron; 1994 Jul; 13(1):11-22. PubMed ID: 8043272
[TBL] [Abstract][Full Text] [Related]
35. Uncovering multiple axonal targeting pathways in hippocampal neurons.
Wisco D; Anderson ED; Chang MC; Norden C; Boiko T; Fölsch H; Winckler B
J Cell Biol; 2003 Sep; 162(7):1317-28. PubMed ID: 14517209
[TBL] [Abstract][Full Text] [Related]
36. Identification of cannabinoid type 1 receptor in dog hair follicles.
Mercati F; Dall'Aglio C; Pascucci L; Boiti C; Ceccarelli P
Acta Histochem; 2012 Jan; 114(1):68-71. PubMed ID: 21414652
[TBL] [Abstract][Full Text] [Related]
37. Identification of a somatodendritic targeting signal in the cytoplasmic domain of the transferrin receptor.
West AE; Neve RL; Buckley KM
J Neurosci; 1997 Aug; 17(16):6038-47. PubMed ID: 9236215
[TBL] [Abstract][Full Text] [Related]
38. Constitutive endocytic cycle of the CB1 cannabinoid receptor.
Leterrier C; Bonnard D; Carrel D; Rossier J; Lenkei Z
J Biol Chem; 2004 Aug; 279(34):36013-21. PubMed ID: 15210689
[TBL] [Abstract][Full Text] [Related]
39. A novel high-throughput assay for the quantitative assessment of receptor trafficking.
Grimsey NL; Narayan PJ; Dragunow M; Glass M
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1377-82. PubMed ID: 18565191
[TBL] [Abstract][Full Text] [Related]
40. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.
Rozenfeld R; Devi LA
FASEB J; 2008 Jul; 22(7):2311-22. PubMed ID: 18267983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
